{"_id": "28483579|None", "id": "28483579", "infons": {}, "passages": [{"infons": {"journal": "Ultrasound Med Biol; 2017 08; 43(8) 1563-1570. doi:10.1016/j.ultrasmedbio.2017.03.014", "year": "2017", "type": "title", "authors": "Zeng J, Zheng J, Huang Z, Chen S, Liu J, Wu T, Zheng R, Lu M", "section": "Title"}, "offset": 0, "text": "Comparison of 2-D Shear Wave Elastography and Transient Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D008103", "type": "Disease"}, "text": "Liver Fibrosis", "locations": [{"offset": 83, "length": 14}]}, {"id": "3", "infons": {"identifier": "MESH:D019694", "type": "Disease"}, "text": "Chronic Hepatitis B", "locations": [{"offset": 101, "length": 19}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 122, "text": "This study compared 2-D shear wave elastography (SWE) and transient elastography (TE) for liver fibrosis staging in patients with chronic hepatitis B (CHB) infection using liver biopsy as the reference standard. Patients with CHB infection who underwent liver biopsy were consecutively included. After exclusions, 257 patients were analyzed. Two-dimensional SWE resulted in a significantly higher rate of reliable measurements (98.1%, 252/257) than TE (93.0%, 239/257) (p = 0.011). Liver stiffness measurements of the two examinations exhibited a strong correlation (r = 0.835, p < 0.001). In patients given a confirmed histologic diagnosis, Spearman's rank coefficients were 0.520 in stage F0 (p < 0.001), 0.684 in stage F1 (p < 0.001), 0.777 in stage F2 (p < 0.001), 0.672 in stage F3 (p < 0.001) and 0.755 in stage F4 (p < 0.001). There were no significant differences between the areas under the receiver operating characteristic (ROC) curves of 2-D SWE and TE for liver fibrosis staging (all p values > 0.05). Two-dimensional SWE had diagnostic accuracy comparable to that of TE for liver fibrosis staging. The measurements that the two techniques provide are not interchangeable.", "sentences": [], "annotations": [{"id": "13", "infons": {"identifier": "MESH:D008103", "type": "Disease"}, "text": "liver fibrosis", "locations": [{"offset": 212, "length": 14}]}, {"id": "14", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 238, "length": 8}]}, {"id": "15", "infons": {"identifier": "MESH:D019694", "type": "Disease"}, "text": "chronic hepatitis B (CHB) infection", "locations": [{"offset": 252, "length": 35}]}, {"id": "16", "infons": {"identifier": "9606", "type": "Species"}, "text": "Patients", "locations": [{"offset": 334, "length": 8}]}, {"id": "17", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 440, "length": 8}]}, {"id": "18", "infons": {"identifier": "MESH:D017093", "type": "Disease"}, "text": "Liver stiffness", "locations": [{"offset": 604, "length": 15}]}, {"id": "19", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 715, "length": 8}]}, {"id": "20", "infons": {"identifier": "MESH:D008103", "type": "Disease"}, "text": "liver fibrosis", "locations": [{"offset": 1091, "length": 14}]}, {"id": "21", "infons": {"identifier": "MESH:D008103", "type": "Disease"}, "text": "liver fibrosis", "locations": [{"offset": 1210, "length": 14}]}], "relations": []}], "relations": [], "pmid": 28483579, "pmcid": null, "created": {"$date": 1643813405108}, "accessions": ["disease@MESH:D008103", "disease@MESH:D017093", "species@9606", "disease@MESH:D019694"], "journal": "Ultrasound Med Biol", "year": 2017, "authors": ["Zeng J", "Zheng J", "Huang Z", "Chen S", "Liu J", "Wu T", "Zheng R", "Lu M"]}
{"_id": "28483578|None", "id": "28483578", "infons": {}, "passages": [{"infons": {"journal": "Biochim. Biophys. Acta; 2017 Jul; 1863(7) 1848-1857. doi:10.1016/j.bbadis.2017.05.002", "year": "2017", "type": "title", "authors": "Zhou CL, Kong DL, Liu JF, Lu ZK, Guo HF, Wang W, Qiu JF, Liu XJ, Wang Y", "section": "Title"}, "offset": 0, "text": "MHC II-, but not MHC II+, hepatic Stellate cells contribute to liver fibrosis of mice in infection with Schistosoma japonicum.", "sentences": [], "annotations": [{"id": "6", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 0, "length": 6}]}, {"id": "7", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 17, "length": 6}]}, {"id": "8", "infons": {"identifier": "MESH:D005355", "type": "Disease"}, "text": "fibrosis", "locations": [{"offset": 69, "length": 8}]}, {"id": "9", "infons": {"identifier": "10090", "type": "Species"}, "text": "mice", "locations": [{"offset": 81, "length": 4}]}, {"id": "10", "infons": {"identifier": "MESH:D007239", "type": "Disease"}, "text": "infection", "locations": [{"offset": 89, "length": 9}]}, {"id": "11", "infons": {"identifier": "6182", "type": "Species"}, "text": "Schistosoma japonicum", "locations": [{"offset": 104, "length": 21}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 127, "text": "Hepatic stellate cells (HSCs) are considered as the main effector cells in vitamin A metabolism and liver fibrosis, as well as in hepatic immune regulation. Recently, researches have revealed that HSCs have plasticity and heterogeneity, which depend on their lobular location and whether liver is normal or injured. This research aimed to explore the biological characteristics and heterogeneity of HSCs in mice with Schistosoma japonicum (S. japonicum) infection, and determine the subpopulation of HSCs in pathogenesis of hepatic fibrosis caused by S. japonicum infection. Results revealed that HSCs significantly increased the expressions of MHC II and fibrogenic genes after S. japonicum infection, and could be classified into MHC II+ HSCs and MHC II- HSCs subsets. Both two HSCs populations suppressed the proliferation of activated CD4+T cells, whereas only MHC II- HSCs displayed a myofibroblast-like phenotype. In response to IFN-gamma, HSCs up-regulated the expressions of MHC II and CIITA, while down-regulated the expression of fibrogenic gene Col1. In addition, praziquantel treatment decreased the expressions of fibrogenic genes in MHC II- HSCs. These results confirmed that HSCs from S. japonicum-infected mice have heterogeneity. The MHC II- alpha-SMA+ HSCs were major subsets of HSCs contributing to liver fibrosis and could be considered as a potential target of praziquantel anti-fibrosis treatment.", "sentences": [], "annotations": [{"id": "34", "infons": {"identifier": "MESH:D014801", "type": "Chemical"}, "text": "vitamin A", "locations": [{"offset": 202, "length": 9}]}, {"id": "35", "infons": {"identifier": "MESH:D008103", "type": "Disease"}, "text": "liver fibrosis", "locations": [{"offset": 227, "length": 14}]}, {"id": "36", "infons": {"identifier": "10090", "type": "Species"}, "text": "mice", "locations": [{"offset": 534, "length": 4}]}, {"id": "37", "infons": {"identifier": "6182", "type": "Species"}, "text": "Schistosoma japonicum", "locations": [{"offset": 544, "length": 21}]}, {"id": "38", "infons": {"identifier": "6182", "type": "Species"}, "text": "S. japonicum", "locations": [{"offset": 567, "length": 12}]}, {"id": "39", "infons": {"identifier": "MESH:D007239", "type": "Disease"}, "text": "infection", "locations": [{"offset": 581, "length": 9}]}, {"id": "40", "infons": {"identifier": "MESH:D005355", "type": "Disease"}, "text": "fibrosis", "locations": [{"offset": 659, "length": 8}]}, {"id": "41", "infons": {"identifier": "MESH:D012554", "type": "Disease"}, "text": "japonicum infection", "locations": [{"offset": 681, "length": 19}]}, {"id": "42", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 772, "length": 6}]}, {"id": "43", "infons": {"identifier": "MESH:D012554", "type": "Disease"}, "text": "japonicum infection", "locations": [{"offset": 809, "length": 19}]}, {"id": "44", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 859, "length": 6}]}, {"id": "45", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 876, "length": 6}]}, {"id": "46", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 992, "length": 6}]}, {"id": "47", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 1110, "length": 6}]}, {"id": "48", "infons": {"identifier": "MESH:D011223", "type": "Chemical"}, "text": "praziquantel", "locations": [{"offset": 1202, "length": 12}]}, {"id": "49", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 1274, "length": 6}]}, {"id": "50", "infons": {"identifier": "MESH:D012554", "type": "Disease"}, "text": "japonicum-infected", "locations": [{"offset": 1330, "length": 18}]}, {"id": "51", "infons": {"identifier": "10090", "type": "Species"}, "text": "mice", "locations": [{"offset": 1349, "length": 4}]}, {"id": "52", "infons": {"identifier": "111364", "type": "Gene"}, "text": "MHC II", "locations": [{"offset": 1378, "length": 6}]}, {"id": "53", "infons": {"identifier": "MESH:D005355", "type": "Disease"}, "text": "fibrosis", "locations": [{"offset": 1451, "length": 8}]}, {"id": "54", "infons": {"identifier": "MESH:D011223", "type": "Chemical"}, "text": "praziquantel", "locations": [{"offset": 1509, "length": 12}]}, {"id": "55", "infons": {"identifier": "MESH:D005355", "type": "Disease"}, "text": "fibrosis", "locations": [{"offset": 1527, "length": 8}]}], "relations": []}], "relations": [], "pmid": 28483578, "pmcid": null, "created": {"$date": 1643813405108}, "accessions": ["gene@111364", "disease@MESH:D007239", "chemical@MESH:D011223", "disease@MESH:D008103", "chemical@MESH:D014801", "species@10090", "disease@MESH:D005355", "species@6182", "disease@MESH:D012554"], "journal": "Biochim. Biophys. Acta", "year": 2017, "authors": ["Zhou CL", "Kong DL", "Liu JF", "Lu ZK", "Guo HF", "Wang W", "Qiu JF", "Liu XJ", "Wang Y"]}
{"_id": "28483577|None", "id": "28483577", "infons": {}, "passages": [{"infons": {"journal": "Biochim. Biophys. Acta; 2017 Jul; 1863(7) 1718-1727. doi:10.1016/j.bbadis.2017.05.003", "year": "2017", "type": "title", "authors": "Ferraro M, Gjomarkaj M, Siena L, Di Vincenzo S, Pace E", "section": "Title"}, "offset": 0, "text": "Formoterol and fluticasone propionate combination improves histone deacetylation and anti-inflammatory activities in bronchial epithelial cells exposed to cigarette smoke.", "sentences": [], "annotations": [{"id": "2", "infons": {"identifier": "MESH:D000068759", "type": "Chemical"}, "text": "Formoterol", "locations": [{"offset": 0, "length": 10}]}, {"id": "3", "infons": {"identifier": "MESH:D000068298", "type": "Chemical"}, "text": "fluticasone propionate", "locations": [{"offset": 15, "length": 22}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 172, "text": "BACKGROUND: The addition of long-acting beta2-agonists (LABAs) to corticosteroids improves asthma control. Cigarette smoke exposure, increasing oxidative stress, may negatively affect corticosteroid responses. The anti-inflammatory effects of formoterol (FO) and fluticasone propionate (FP) in human bronchial epithelial cells exposed to cigarette smoke extracts (CSE) are unknown. AIMS: This study explored whether FP, alone and in combination with FO, in human bronchial epithelial cellline (16-HBE) and primary bronchial epithelial cells (NHBE), counteracted some CSE-mediated effects and in particular some of the molecular mechanisms of corticosteroid resistance. METHODS: 16-HBE and NHBE were stimulated with CSE, FP and FO alone or combined. HDAC3 and HDAC2 activity, nuclear translocation of GR and NF-kappaB, pERK1/2/tERK1/2 ratio, IL-8, TNF-alpha, IL-1beta mRNA expression, and mitochondrial ROS were evaluated. Actin reorganization in neutrophils was assessed by fluorescence microscopy using the phalloidin method. RESULTS: In 16-HBE, CSE decreased expression/activity of HDAC3, activity of HDAC2, nuclear translocation of GR and increased nuclear NF-kappaB expression, pERK 1/2/tERK1/2 ratio, and mRNA expression of inflammatory cytokines. In NHBE, CSE increased mRNA expression of inflammatory cytokines and supernatants from CSE exposed NHBE increased actin reorganization in neutrophils. FP combined with FO reverted all these phenomena in CSE stimulated 16-HBE cells as well as in NHBE cells. CONCLUSIONS: The present study provides compelling evidences that FP combined with FO may contribute to revert some processes related to steroid resistance induced by oxidative stress due to cigarette smoke exposure increasing the anti-inflammatory effects of FP.", "sentences": [], "annotations": [{"id": "24", "infons": {"identifier": "MESH:D001249", "type": "Disease"}, "text": "asthma", "locations": [{"offset": 263, "length": 6}]}, {"id": "25", "infons": {"identifier": "MESH:D000068759", "type": "Chemical"}, "text": "formoterol", "locations": [{"offset": 415, "length": 10}]}, {"id": "26", "infons": {"identifier": "MESH:D000068759", "type": "Chemical"}, "text": "FO", "locations": [{"offset": 427, "length": 2}]}, {"id": "27", "infons": {"identifier": "MESH:D000068298", "type": "Chemical"}, "text": "fluticasone propionate", "locations": [{"offset": 435, "length": 22}]}, {"id": "28", "infons": {"identifier": "MESH:D000068298", "type": "Chemical"}, "text": "FP", "locations": [{"offset": 459, "length": 2}]}, {"id": "29", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 466, "length": 5}]}, {"id": "30", "infons": {"identifier": "9606", "type": "Species"}, "text": "human", "locations": [{"offset": 629, "length": 5}]}, {"id": "31", "infons": {"identifier": "CVCL_0112;NCBITaxID:9606", "type": "CellLine"}, "text": "16-HBE", "locations": [{"offset": 666, "length": 6}]}, {"id": "32", "infons": {"identifier": "CVCL_0112;NCBITaxID:9606", "type": "CellLine"}, "text": "16-HBE", "locations": [{"offset": 850, "length": 6}]}, {"id": "33", "infons": {"identifier": "8841", "type": "Gene", "ncbi_homologene": "48250"}, "text": "HDAC3", "locations": [{"offset": 921, "length": 5}]}, {"id": "34", "infons": {"identifier": "3066", "type": "Gene", "ncbi_homologene": "68187"}, "text": "HDAC2", "locations": [{"offset": 931, "length": 5}]}, {"id": "35", "infons": {"identifier": "3576", "type": "Gene", "ncbi_homologene": "47937"}, "text": "IL-8", "locations": [{"offset": 1013, "length": 4}]}, {"id": "36", "infons": {"identifier": "7124", "type": "Gene", "ncbi_homologene": "496"}, "text": "TNF-alpha", "locations": [{"offset": 1019, "length": 9}]}, {"id": "37", "infons": {"identifier": "3552", "type": "Gene", "ncbi_homologene": "480"}, "text": "IL-1beta", "locations": [{"offset": 1030, "length": 8}]}, {"id": "38", "infons": {"identifier": "-", "type": "Chemical"}, "text": "ROS", "locations": [{"offset": 1074, "length": 3}]}, {"id": "39", "infons": {"identifier": "CVCL_0112;NCBITaxID:9606", "type": "CellLine"}, "text": "16-HBE", "locations": [{"offset": 1211, "length": 6}]}, {"id": "40", "infons": {"identifier": "8841", "type": "Gene", "ncbi_homologene": "48250"}, "text": "HDAC3", "locations": [{"offset": 1256, "length": 5}]}, {"id": "41", "infons": {"identifier": "3066", "type": "Gene", "ncbi_homologene": "68187"}, "text": "HDAC2", "locations": [{"offset": 1275, "length": 5}]}, {"id": "42", "infons": {"identifier": "CVCL_0112;NCBITaxID:9606", "type": "CellLine"}, "text": "16-HBE", "locations": [{"offset": 1643, "length": 6}]}, {"id": "43", "infons": {"identifier": "MESH:D013256", "type": "Chemical"}, "text": "steroid", "locations": [{"offset": 1819, "length": 7}]}], "relations": []}], "relations": [], "pmid": 28483577, "pmcid": null, "created": {"$date": 1643813405108}, "accessions": ["disease@MESH:D001249", "gene@8841", "gene@3576", "cellline@CVCL_0112;NCBITaxID:9606", "chemical@MESH:D000068298", "gene@7124", "gene@3552", "chemical@MESH:D000068759", "chemical@-", "species@9606", "gene@3066", "chemical@MESH:D013256"], "journal": "Biochim. Biophys. Acta", "year": 2017, "authors": ["Ferraro M", "Gjomarkaj M", "Siena L", "Di Vincenzo S", "Pace E"]}
